M. Apple

发表

Arrest of cancer in mice by therapy with normal metabolites. II. Indefinite survirors among mice treated with mixtures of 2-oxopropanal (NSC-79019) and 2,3-dihydroxypropanal (NSC67934).

M. Apple, D. M. Greenberg, 1968, Cancer chemotherapy reports.

An NMR study of the interaction of daunomycin with dinucleotides and dinucleoside phosphates.

P. Kollman, T. James, M. Apple, 1980, Biochimica et Biophysica Acta.

Refractory megaloblastic anemia with myeloperoxidase-deficient neutrophils.

R. Lehrer, M. Apple, L. Goldberg, 1972, Annals of internal medicine.

Production, Isolation, and Properties of Azetomycins

M. Apple, J. Formica, 1976, Antimicrobial Agents and Chemotherapy.

Active Intervention to Prevent Cancer in Vivo with Prophylactic Drugs

M. Apple, 1975 .

Chapter 26. Reverse Transcription and Its Inhibitors

M. Apple, 1973 .

Inhibition of cancer growth in mice by a normal metabolite.

M. Apple, D. M. Greenberg, 1967, Life sciences.

New Anticancer Drug Design: Past and Future Strategies

M. Apple, 1977 .

Thiophene analogs of sulfanilamide: bacterial growth inhibitors.

A. Naik, J. Craig, M. Apple, 1968, Journal of pharmaceutical sciences.

Selective cancer growth inhibition in mice by dihydroxypropanal without concomitant inhibition of bone marrow or other normal tissue.

M. Apple, D. M. Greenberg, F. Ludwig, 1970, Oncology.

The salish consortium for the improvement of science teaching preparation and development

R. Yager, M. Apple, H. Brunkhorst, 1993 .

Inhibitory effect of DL-2-mercapto-3-hydroxypropanal on growth of transplantable cancers in mice.

M. Apple, D. M. Greenberg, 1969, Cancer chemotherapy reports.